# US 2015/0173830 A1 · Treatment structure and methods of use

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0173830 A1
- Document ID: US20150173830A1
- Status: Published application
- Kind: A1
- Application number: 14/581,638
- Filed: 2014-12-23
- Published: 2015-06-25
- Earliest claimed: 2013-12-23
- Inventors: Eric JOHNSON; Jeremy STIGALL
- Web page: https://patentgrep.com/patent/US20150173830A1

## CPC

- A61B 18/1492: {having a flexible, catheter-like structure, e.g. for heart ablation (A61B18/1477 takes precedence)}
- A61B 5/061: {Determining position of a probe within the body employing means separate from the probe, e.g. sensing internal probe position employing impedance electrodes on the surface of the body (A61B1/00158 takes precedence)}
- A61B 5/201: {Assessing renal or kidney functions}
- A61B 5/4005: {for evaluating the sensory system (A61B5/12, A61B5/4058 take precedence)}
- A61B 5/4035: {Evaluating the autonomic nervous system}
- A61B 8/0841: {for locating instruments}
- A61B 8/12: in body cavities or body tracts, e.g. by using catheters
- A61B 2018/0016: {Energy applicators arranged in a two- or three dimensional array}
- A61B 2018/00214: {Expandable means emitting energy, e.g. by elements carried thereon}
- A61B 2018/00404: {Blood vessels other than those in or around the heart}
- A61B 2018/00434: {Neural system}
- A61B 2018/00511: {Kidney}
- A61B 2018/00982: {combined with or comprising means for visual or photographic inspections inside the body, e.g. endoscopes}
- A61B 2018/0212: {using an instrument inserted into a body lumen, e.g. catheter}
- A61B 2018/1435: {Spiral}
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

Catheter based ablation devices, systems, and methods for achieving intraluminal and/or transluminal neuromodulation, stimulation or ablation by intraluminal access are disclosed herein. One aspect of the present application, for example, is directed to devices, systems, and methods that incorporate a spiral support frame treatment device on an elongate shaft or as a temporary or permanently implanted therapy device. The elongated shaft is sized and configured to deliver a spiral treatment device to a treatment position via an intravascular path. Intraluminal and transluminal neuromodulation, stimulation or ablation or other therapeutic outcomes may be achieved via energy delivered via the spiral element. One therapy includes modulation of neural fibers that contribute to or alter vascular structures that feed or perfuse the neural fibers.

## Claims

### Claim at position 1

-82. (canceled)

### Claim 83

An implantable treatment apparatus, comprising:
an elongated shaft having a proximal portion, a distal portion having a spiral support frame;
at least one treatment element borne by the support frame, wherein the support frame is configured for delivery to and implantation within a human patient adjacent to a treatment location; and
wherein the treatment element is configured for positioning against a portion of the anatomy of the patient in a position suited to the therapeutic range or therapy modality of the at least one treatment element borne by the support frame.

### Claim 84 (depends on 83)

The implantable treatment apparatus of claim 83, wherein the treatment location is accessible and the support frame is configured for delivery via an artery or a vein.

### Claim 85 (depends on 83)

The implantable treatment apparatus of claim 83, wherein the treatment location is accessible and the support frame is configured for delivery via a minimally invasive, laparoscopic or arthroscopic or single port access delivery system.

### Claim 86 (depends on 83)

The implantable treatment apparatus of claim 83, wherein the treatment location is accessible and the support frame is configured for delivery via a lumen or natural orifice of the patient.

### Claim 87

An intraluminal treatment apparatus, comprising:
an elongated shaft having a proximal portion in communication with an energy source and a distal portion coupled to a spiral support frame;
at least one treatment element borne by the spiral support frame and connected via the elongated shaft to the energy source, wherein the support frame is configured for intravascular delivery to a transluminal therapy site in a patient; and
wherein the treatment element is configured for positioning against an interior wall of the lumen to modulate, stimulate or ablate a neural tissue at the transluminal treatment site in the patient.

### Claim 88 (depends on 87)

The intraluminal treatment apparatus of claim 87, wherein the at least one treatment device is positioned on one side of a crossover of the spiral support frame.

### Claim 89 (depends on 87)

The intraluminal treatment apparatus of claim 87, wherein the at least one treatment device further comprises at least one treatment device on a first spiral support member of the spiral support frame and at least one treatment device on a second spiral support member of the spiral support frame.

### Claim 90 (depends on 87)

The intraluminal treatment apparatus of claim 87, wherein the at least one treatment device further comprises at least one treatment device on a first spiral support member comprising a plurality of individually controlled treatment devices on a first spiral support member of the spiral support frame and at least one treatment device on the second spiral support member comprising a plurality of individually controlled treatment devices on a second spiral support member of the spiral support frame.

### Claim 91

A method for spiral support frame based stimulation, neuromodulation, or ablation, comprising:
positioning a spiral support frame having a therapeutic element within the vasculature of a human patient; and
reducing neural traffic to and/or from or along one or more nerves adjacent the vasculature via the therapeutic element, wherein reducing the neural traffic to and/or from or along the nerves therapeutically treats a diagnosed condition or disease associated with the one or more nerves of the patient.

### Claim 92 (depends on 91)

The method of claim 91, wherein positioning a spiral support frame therapeutic device within a patient comprises positioning a catheter using fluoroscopic guidance.

### Claim 93 (depends on 91)

The method of claim 91, wherein positioning a spiral support frame therapeutic device within a patient comprises positioning a catheter using intra vascular ultrasound.

### Claim 94 (depends on 91)

The method of claim 91, wherein reducing neural traffic comprises transferring energy via the spiral support frame.

### Claim 95 (depends on 94)

The method of claim 94, wherein transferring energy via the spiral support frame comprises ablating one or more nerves or a portion thereof in proximity to the spiral support frame.

### Claim 96 (depends on 94)

The method of claim 94, wherein transferring energy via the spiral support frame comprises delivering radiofrequency energy via an element borne by the support frame or extending from a conduit of the support frame.

### Claim 97 (depends on 91)

The method of claim 91, wherein reducing neural traffic to and/or along comprises blocking neural traffic to and/or from an organ of the patient.

### Claim 98 (depends on 91)

The method of claim 91, wherein reducing neural traffic comprises denervating an organ of the patient.

### Claim 99 (depends on 91)

The method of claim 91, wherein reducing neural traffic comprises modulating sympathetic nerves that innervate an organ of the patient.

### Claim 100 (depends on 91)

The method of claim 91, wherein the step of positioning the spiral support frame further comprises positioning the spiral support frame having the therapeutic element within a renal artery of the human patient; and
wherein the step of reducing neural traffic further comprises reducing neural traffic to and/or from a kidney of the patient via the therapeutic element, wherein reducing the neural traffic to and/or from the kidney therapeutically treats a diagnosed condition or disease associated with cardio-renal function of the patient.

### Claim 101 (depends on 91)

The method of claim 91, further comprising:
positioning the spiral support frame having the therapeutic element within a renal artery of the human patient; and
ablating nerves that innervate a kidney of the patient via the therapeutic element, wherein ablating the nerves results in a therapeutically beneficial reduction in blood pressure in the patient.

### Claim 102 (depends on 91)

The method of claim 91, further comprising ablating nerves that innervate a portion of the vasculature of the patient via the therapeutic element, wherein ablating the nerves results in a therapeutically beneficial reduction in a targeted central sympathetic overactivity in the patient.
